InvestorsHub Logo
Followers 80
Posts 24703
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Monday, 08/07/2017 8:17:45 AM

Monday, August 07, 2017 8:17:45 AM

Post# of 27622
CYCC - 1.69 Pre-market now at 1.79/1.80

Cyclacel Announces Selection of Recommended Phase 2 Dose for CYC065 and Evidence of Durable Target Engagement and Mcl-1 Biomarker Suppression



Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.